Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-25 @ 9:55 PM
Study NCT ID:
NCT03556358
Status:
COMPLETED
Last Update Posted:
2022-01-14
First Post:
2018-06-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer
Sponsor:
Tanvex BioPharma USA, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-04
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-01
First Submit QC Date:
None
Study First Post Date:
2018-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-28
Results First Submit QC Date:
None
Results First Post Date:
2022-01-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-07
Last Update Post Date:
2022-01-14
Last Update Post Date Type:
ACTUAL